Skip to main content

Table 1 Patient pre-operative characteristics. Data are shown as median (25%; 75%) quartiles or as n (%) patients

From: The need for post-operative vasopressor infusions after major gynae-oncologic surgery within an ERAS (Enhanced Recovery After Surgery) pathway

Pre-operative; number of patients = 324

 Age (years)

66.5 (56–74)

 Weight (kg)

69 (60–82)

 Haemoglobin (g/l)

122 (109–134)

 Albumin (g/l)

42 (40–44)

 Tumour type, n (%)

  Ovarian

244 (75.30%)

   Benign

31

   Borderline

6

   Malignant

207

  Endometrial/uterine

62 (10%)

  Cervix

2 (0.61%)

  Vulva

2 (0.61%)

  Vagina

1 (0.31%)

  Bowel

6 (1.85%)

  Other (GI/breast)

4 (1.23%)

  Unknown primary

3 (0.93%)

 P-POSSUM predicted risk of mortality (%)

5.8 (1.7–16.9)

 P-POSSUM predicted risk of morbidity (%)

74.1 (38.5–92.5)

 Neoadjuvant chemotherapy, n (%)

126 (39%)